The effects of weight loss and salt reduction on visit-to-visit blood pressure variability: Results from a multicenter randomized controlled trial

Journal of Hypertension

Volumn 32, Issue 4, 2014, Pages 840-848

  Diaz, Keith M ^a,b   Muntner, Paul ^c   Levitan, Emily B ^c   Brown, Michael D ^d   Babbitt, Dianne M ^b   Shimbo, Daichi ^a  

^a Department of Medicine   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Blood pressure variability; Hypertension; Lifestyle; Sodium reduction; Weight loss

Indexed keywords

SODIUM CHLORIDE; SALT INTAKE;

ADULT; AMBULATORY CARE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; MULTICENTER STUDY; OBESITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REDUCTION; SODIUM EXCRETION; SODIUM INTAKE; SODIUM URINE LEVEL; WEIGHT REDUCTION; BLOOD PRESSURE; BODY WEIGHT; CLINICAL TRIAL; LOW CALORY DIET; SALT INTAKE; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; VISIT TO VISIT BLOOD PRESSURE VARIABILITY;

ADULT; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BODY WEIGHT; DIET, REDUCING; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SODIUM CHLORIDE, DIETARY; WEIGHT LOSS;

EID: 84896314163     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000080     Document Type: Article

References (32)

1. Grove JS, Reed DM, Yano K, Hwang LJ. Variability in systolic blood pressure-a risk factor for coronary heart disease? Am J Epidemiol 1997; 145:771-776
2. Hsieh YT, Tu ST, Cho TJ, Chang SJ, Chen JF, Hsieh MC. Visit-to-visit variability in blood pressure strongly predicts all-cause mortality in patients with type 2 diabetes: A 5.5-year prospective analysis. Eur J Clin Invest 2012; 42:245-253
3. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: Findings from NHANES III, 1988 to 1994. Hypertension 2011; 57:160-166
4. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375:895-905
5. Shimbo D, Newman JD, Aragaki AK, LaMonte MJ, Bavry AA, Allison M, et al. Association between annual visit-to-visit blood pressure variability and stroke in postmenopausal women: Data from the Women's Health Initiative. Hypertension 2012; 60:625-630
6. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, et al. Effects of beta blockers and calcium-channel blockers on withinindividual variability in blood pressure and risk of stroke. Lancet Neurol 2010; 9:469-480
7. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252
8. He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: A meta-analysis of randomized trials. Implications for public health. J Hum Hypertens 2002; 16:761-770
9. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: A meta-analysis of randomized controlled trials. Hypertension 2003; 42:878-884
10. Hebert PR, Bolt RJ, Borhani NO, Cook NR, Cohen JD, Cutler JA, et al. Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (phase II). Ann Epidemiol 1995; 5:130-139
11. Hollis JF, Satterfield S, Smith F, Fouad M, Allender PS, Borhani N, et al. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Ann Epidemiol 1995; 5:140-148
12. Lasser VI, Raczynski JM, Stevens VJ, Mattfeldt-Beman MK, Kumanyika S, Evans M, et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Ann Epidemiol 1995; 5:156-164
13. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with highnormal blood pressure. The Trials of Hypertension Prevention, phase II. Arch Intern Med 1997; 157:657-667
14. Levitan EB, Kaciroti N, Oparil S, Julius S, Muntner P. Blood pressure measurement device, number and timing of visits, and intra-individual visit-to-visit variability of blood pressure. J Clin Hypertens 2012; 14:744-750
15. Levitan EB, Kaciroti N, Oparil S, Julius S, Muntner P. Relationships between metrics of visit-to-visit variability of blood pressure. J Hum Hypertens 2013; 27:589-593
16. Cook NR, Kumanyika SK, Cutler JA, Whelton PK. Trials of Hypertension Prevention Collaborative Research Group. Dose-response of sodium excretion and blood pressure change among overweight, nonhypertensive adults in a 3-year dietary intervention study. J Hum Hypertens 2005; 19:47-54
17. Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith West D, et al. Trials of Hypertension Prevention Collaborative Research Group. Long-term weight loss and changes in blood pressure: Results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 2001; 134:1-11
18. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensivedrug class on interindividual variation in blood pressure and risk of stroke: A systematic review and meta-analysis. Lancet 2010; 375:906-915
19. Dolan E, O'Brien E. Blood pressure variability: Clarity for clinical practice. Hypertension 2010; 56:179-181
20. Brill JB. Lifestyle intervention strategies for the prevention and treatment of hypertension: A review. Am J Lifestyle Med 2011; 5:346-360
21. Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: Three-year effects of dietary changes on blood pressure. Arch Intern Med 1990; 150:153-162
22. Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, et al. Effects of comprehensive lifestyle modification on blood pressure control: Main results of the PREMIER clinical trial. JAMA 2003; 289:2083-2093
23. Whelton PK, Kumanyika SK, Cook NR, Cutler JA, Borhani NO, Hennekens CH, et al. Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: Results from phase 1 of the Trials of Hypertension Prevention. Am J Clin Nutr 1997; 65:652S-760S
24. Stevens VJ, Corrigan SA, Obarzanek E, Bernauer E, Cook NR, Hebert P, et al. Weight loss intervention in phase 1 of the trials of hypertension prevention. Arch Intern Med 1993; 153:849-858
25. Kumanyika SK, Bowen D, Rolls BJ, Van Horn L, Perri MG, Czajkowski SM, Schron E. Maintenance of dietary behavior change. Health Psych 2000; 19:42-56
26. Wu T, Gao X, Chen M, Van Dam RM. Long-term effectiveness of dietplus- exercise interventions vs. diet-only interventions for weight loss: A meta-analysis. Obes Rev 2009; 10:313-323
27. Diaz VA, Mainous AG 3rd, Everett CJ. The association between weight fluctuation and mortality: Results from a population-based cohort study. J Commun Health 2005; 30:153-165
28. Hamm P, Shekelle RB, Stamler J. Large fluctuations in body weight during young adulthood and twenty-five-year risk of coronary death in men. Am J Epidemiol 1989; 129:312-318
29. Peters ET, Seidell JC, Menotti A, Arayanis C, Dontas A, Fidanza F, et al. Changes in body weight in relation to mortality in 6441 European middle-aged men: The Seven Countries Study. Int J Obes 1995; 19:862-868
30. Montani JP, Viecelli AK, Prevot A, Dulloo AG. Weight cycling during growth and beyond as a risk factor for later cardiovascular diseases: The 'repeated overshoot' theory. Int J Obes 2006; 30:S58-S66
31. Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis. Circulation 2012; 126:569-578
32. O'Brien E, Mee F, Atkins N, O'Malley K. Inaccuracy of the Hawksley random zero sphygmomanometer. Lancet 1990; 336:1465-1468